当几乎同一时期成立的竞争对手如珀莱雅、上美股份、丸美生物等早已登陆资本市场，近日向港交所递交上市申请的自然堂显得有 些"姗姗来迟"。关于此次募集资金的用途，自然堂给出了较为明确的规划——提升品牌力、丰富品牌矩阵、建立国际品牌知名 度……而这背后是自然堂面临的长期以来对主品牌自然堂的依赖，以及销售费用持续走高等现实情况。 与几乎同一时期成立的珀莱雅、丸美生物、上美股份等国货美妆品牌先后登陆资本市场不同，一直以来自然堂在资本市场迟迟未有 动作，这也曾多次引发业界猜测，其中被谈到最多的原因不乏不缺钱、想掌握更多主动权等。 如今，启动上市进程，自然堂想改变了？ "相对而言，港股上市对于企业未来走向海外市场、开启国际化拓展更为有利。所以，这时候选择在港股上市，应该也是企业出于 对未来发展的需要。上市可以增强企业的资本实力，推动企业内部管理更加规范化以及通过上市获得更多资本支持，通过并购等方 式增强企业的实力。"深圳市思其晟公司CEO伍岱麒给出自己的观点。 根据招股书数据，2022年至2024年，自然堂收入分别为42.92亿元、44.42亿元、46.01亿元，2023年及2024年增速分别为3.49%、 3.58%。20 ...

证券之星消息，10月13日化妆品板块较上一交易日下跌1.87%，嘉亨家化领跌。当日上证指数报收于 3889.5，下跌0.19%。深证成指报收于13231.47，下跌0.93%。化妆品板块个股涨跌见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300955 嘉亨家化 | | 1070.30万 | 2.95% | - 1069.71万 | 2.95% | -2140.01万 | -5.90% | | 603630 | 拉芳家化 | 211.14万 | 2.09% | -55.36万 | -0.55% | -155.79万 | -1.54% | | 600223 | 福瑞达 | 61.87万 | 1.21% | 92.31万 | 1.80% | -154.19万 | -3.00% | | 603983 丸美生物 | | -15.15万 | -0.19% | -387.52万 | -4.75% | 402.67万 ...

国货美妆品牌走向全球市场，大的背景是在科研方面不断取得突破。以韩束为例，其长期深耕"肽"类研 究，通过持续22年的科研投入，韩束构建了参与国际竞争的技术底气。2024年，韩束自研的"环六 肽-9"成分成功通过备案，打破国际品牌在抗衰原料领域的技术垄断。 根据上美股份发布的财报，2025年上半年，其收入为41.08亿元，同比增长17.3%；上半年公司利润为 5.56亿元，同比增长约35%。 受益于良好的业绩表现、研发突破及全球化布局的推进，上美股份今年以来股价大幅上涨。Wind数据 显示，截至10月13日，上美股份今年以来累计上涨180%，区间最高涨幅近200%。截至10月13日，上美 股份市值382亿港元。 作为上美股份旗下核心品牌，韩束今年上半年收入为33.44亿元，同比增长14.3%，占上美股份上半年收 入的81.4%。韩束的王牌产品韩束红蛮腰套盒，全渠道累计销售额已超过1650万套，并长期占据抖音护 肤套盒榜单第一名。 上美股份（02145.HK）旗下国货美妆品牌韩束正加速全球化布局。10月13日，韩束官宣王嘉尔担任品 牌全球代言人。据了解，这是王嘉尔首次代言国货美妆品牌。韩束表示，此次合作是"国货顶流 ...

Group 1 - Harbin Fuirjia Technology Co., Ltd. has completed the filing of its Articles of Association and related business registration changes [1] - The company held its second board meeting on August 21, 2025, and the first extraordinary shareholders' meeting on September 8, 2025, where amendments to the Articles of Association were approved [1] - The company has made significant personnel changes, electing Xu Chong as the employee representative director and appointing Li Zhengde as the financial officer [1] Group 2 - The completion of these changes may have a significant impact on the company's governance and operations, warranting market attention [1]

Core Viewpoint - 嘉亨家化's stock price dropped by 15.70% on the trading day, with a turnover rate of 11.25% and a total transaction amount of 363 million yuan, indicating significant market activity and investor reaction [2] Trading Performance - The stock experienced a trading volume of 363 million yuan and a price fluctuation of 8.59% throughout the day [2] - The stock was listed on the Shenzhen Stock Exchange's watch list due to its closing price drop of 15.70% [2] Institutional Activity - Institutional investors net sold 61.21 million yuan worth of shares, while retail trading desks collectively net bought 347,500 yuan [2] - The top five trading desks accounted for a total transaction amount of 138 million yuan, with a buying amount of 38.78 million yuan and a selling amount of 99.63 million yuan, resulting in a net sell of 60.85 million yuan [2] Fund Flow - The stock saw a net inflow of 1.42 million yuan from major funds, with a significant outflow of 3.29 million yuan from large orders and an inflow of 4.72 million yuan from smaller orders [2] - Over the past five days, the net inflow of major funds amounted to 73.93 million yuan [2] Detailed Trading Data - The top buying and selling desks included several institutional specialized seats, with the largest buy amounting to 12.58 million yuan and the largest sell reaching 40.05 million yuan [2] - Specific trading desks such as 东方财富证券 and 西南证券 were involved in both buying and selling activities, reflecting a mixed sentiment among investors [2]

Core Viewpoint - The successful registration of bio-synthesized royal jelly acid by Furuida, a subsidiary of Lushang Group, marks a significant breakthrough in the Chinese cosmetics industry, enabling the large-scale application of this active ingredient and leading innovation in the sector [1][8]. Group 1: Royal Jelly and Its Applications - Royal jelly is a complex substance secreted by worker bees, consisting of water, proteins, sugars, lipids, and trace components, and is known for its strong biological activity with potential applications in food, medical materials, health products, and cosmetics [3][4]. - Historically, royal jelly has been used in skincare, with records dating back over 2000 years in ancient Egypt and China [3]. Group 2: Benefits of Royal Jelly Acid - Royal jelly exhibits multiple benefits in cosmetics, including anti-aging properties by promoting collagen production and inhibiting skin photoaging [4][5]. - It also has antibacterial properties, effectively inhibiting Staphylococcus aureus and other microbes [5]. - Additionally, royal jelly shows strong anti-inflammatory effects, enhancing skin barrier function and hydration [5]. Group 3: Challenges in Industrialization - The core component of royal jelly, 10-hydroxy-2-decenoic acid (royal jelly acid), is present in low concentrations (1.4%-2.4%), making extraction and application challenging [6][7]. - Despite China being the largest producer of royal jelly, the high cost and limited availability of royal jelly acid have hindered its widespread use in cosmetics [7][8]. Group 4: Industry Significance of Furuida's Breakthrough - Furuida's successful registration of royal jelly acid as a new cosmetic ingredient represents a significant advancement in the domestic cosmetics industry, breaking the research and application gap in this area [8][9]. - The innovative biosynthesis technology developed by Furuida enhances the efficiency and yield of royal jelly acid production, addressing the challenges of high costs and limited availability [9][10]. - The discovery of royal jelly acid's skin barrier protection and anti-aging effects further solidifies its potential as a key ingredient in cosmetics [10]. Group 5: Broader Implications for the Cosmetics Industry - The success of royal jelly acid is indicative of a broader trend in the Chinese cosmetics industry towards reducing reliance on foreign technology and increasing domestic innovation [11]. - The number of newly registered cosmetic ingredients in China is at a historical high, with over 40% being supported by synthetic biology, reflecting a strategic shift towards "domestic substitution" in response to global supply chain uncertainties [11].

（文章来源：每日经济新闻） 每经AI快讯，10月13日，港股巨子生物(02367.HK)跌超5%，截至发稿，跌5.33%，报50.6港元，成交额 6.28亿港元。 ...

消息面上，2025年双十一电商大促已经提前启动。华泰证券此前指出，在25Q2面临一定外部因素影响 的背景下，巨子生物上半年收入与利润仍能双增，且盈利能力维持相对稳定，彰显品牌定力与业绩韧 性。双11旺季临近，公司品牌宣传/达人推广等活动有望逐步恢复并带动公司H2增长提速。 巨子生物(02367)再跌超5%，截至发稿，跌5.33%，报50.6港元，成交额6.28亿港元。 值得注意的是，华熙生物9月底表示，已联合国家计量院等多家第三方检测机构对相关企业的相关产品 展开检测，结果几十份检测结果均显示，相关产品中的重组胶原蛋白添加量未达标。华熙生物表 示，"已将数十份检测报告提交国家药品监督管理局。"分析人士称，可复美在今年618电商大促中失 意，市场将重点关注双11期间可复美电商销售表现。 ...

值得注意的是，华熙生物9月底表示，已联合国家计量院等多家第三方检测机构对相关企业的相关产品 展开检测，结果几十份检测结果均显示，相关产品中的重组胶原蛋白添加量未达标。华熙生物表 示，"已将数十份检测报告提交国家药品监督管理局。"分析人士称，可复美在今年618电商大促中失 意，市场将重点关注双11期间可复美电商销售表现。 智通财经APP获悉，巨子生物(02367)再跌超5%，截至发稿，跌5.33%，报50.6港元，成交额6.28亿港 元。 消息面上，2025年双十一电商大促已经提前启动。华泰证券此前指出，在25Q2面临一定外部因素影响 的背景下，巨子生物上半年收入与利润仍能双增，且盈利能力维持相对稳定，彰显品牌定力与业绩韧 性。双11旺季临近，公司品牌宣传/达人推广等活动有望逐步恢复并带动公司H2增长提速。 ...

近日，自然堂向港交所递交了上市申请。 早在2023年，自然堂（未更名前的名称"伽蓝集团"）就有上市消息传出，而直到现在，这家拥有24年历 史的国货美妆巨头的上市之路才迎来实质性进展。 "攻占"下沉市场？ 海通证券分析师将中国化妆品零售渠道划成了四个阶段：2004年前的百货时代；2011年前的KA/CS （Key Account/Cosmetic Shop；大型卖场/化妆品专营店或连锁门店）；2011-2017年传统电商渠道； 2018年以来的社媒电商时代。 （文/霍东阳 编辑/张广凯） 不过，对于成立于2000年前后的国产美妆公司来说，零售渠道的阶段有所不同，它们身上最重要的标签 之一是"农村包围城市"。 在这批国产美妆品牌成立之初，国际大牌已凭借强大的品牌力和资金实力，牢牢占据了一二线城市的百 货商场渠道，它们只能选择下沉到国际品牌渗透率较低的三四线城镇及乡镇，通过成千上万的CS渠道 网点触达最广大的消费群体，完成最初的资本和品牌积累。 自然堂也是在这一阶段成立的。2001年，郑春颖在上海创立了自然堂，提出"打造中国人自己的世界级 品牌"的愿景。 自然堂的渠道策略经历了三个明显的阶段：在初期，自然堂一度占据 ...